biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Dr. Mei Mei Tian...

<< Previous

Bullboard Posts

Next >>

Post by Sniper007on Dec 02, 2020 8:42pm

394 Views

Post# 32023555

Dr. Mei Mei Tian...

Clearly a world class scientist and indeed "eloquently spoken". She is a gem! So, very impressed. We are very lucky to have her.

I'm not sure how much uninformed investors would understand the science jargin of the BBB and XB3 but coming from someone that knows a lot about it, she blew my socks off with her ability to communicate the science in a clear and concise manner. Well done Dr. Mei Mei!

DrDR talked about some good talk too. Sounds like exciting news ahead. Looking forward to it.

Sniper

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario